Carisma Therapeutics (CARM) Earnings Date, Estimates & Call Transcripts → Now Open: Crypto emergency update (From InvestorPlace) (Ad) Free CARM Stock Alerts $1.71 +0.02 (+1.18%) (As of 04/18/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueCARM Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.CARM Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad InvestorPlaceYou’re invited: Biggest crypto event of 2024During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.Just click here to sign up and be among the first to get it. Carisma Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20242($0.47)($0.26)($0.37)Q2 20242($0.45)($0.27)($0.36)Q3 20242($0.43)($0.29)($0.36)Q4 20242($0.47)($0.26)($0.37)FY 20248($1.82)($1.08)($1.45)Q1 20251($0.48)($0.48)($0.48)Q2 20251($0.50)($0.50)($0.50)Q3 20251($0.54)($0.54)($0.54)Q4 20251($0.56)($0.56)($0.56)FY 20254($2.08)($2.08)($2.08) Get Carisma Therapeutics Earnings AlertsEnter your email address below to receive the latest news and earnings results for CARM and its competitors with MarketBeat's FREE daily newsletter. CARM Earnings Date and InformationCarisma Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 9th, 2024 based off prior year's report dates.Read More Carisma Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 5/9/2024Estimated)------- 11/9/2023Q3 2023($0.60)($0.53)+$0.07($0.53)-$3.83 million8/10/2023Q2 2023($0.66)($0.49)+$0.17($0.49)-$3.56 million5/11/2023Q1 2023-($1.93)($1.93)($1.93)-$3.24 million2/28/2023Q4 2022($2.20)($0.80)+$1.40($0.80)--11/7/2022Q3 2022($1.60)$2.80+$4.40$3.60-$0.04 million8/8/2022Q2 2022($2.60)($1.00)+$1.60$1.20-- Get the Latest News and Ratings for CARM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Carisma Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 2/28/2022Q4 2021($1.60)$0.40+$2.00--$20.00 million11/8/2021Q3 2021($1.40)($0.40)+$1.00($8.00)--8/9/2021Q2 2021($1.20)($1.40)($0.20)$0.20$2.40 million$2.23 million5/10/2021Q1 2021($1.20)($7.00)($5.80)($7.00)-$4.31 million Carisma Therapeutics Earnings - Frequently Asked Questions When is Carisma Therapeutics's earnings date? Carisma Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 9th, 2024 based off last year's report dates. Learn more on CARM's earnings history. How much revenue does Carisma Therapeutics generate each year? Carisma Therapeutics (NASDAQ:CARM) has a recorded annual revenue of $14.92 million. How much profit does Carisma Therapeutics generate each year? Carisma Therapeutics (NASDAQ:CARM) has a recorded net income of -$86.88 million. CARM has generated -$3.47 earnings per share over the last four quarters. What is Carisma Therapeutics's EPS forecast for next year? Carisma Therapeutics's earnings are expected to grow from ($1.65) per share to ($1.52) per share in the next year. More Earnings Resources from MarketBeat Related Companies: CRVS Earnings Results CUE Earnings Results RLYB Earnings Results IMMX Earnings Results CELU Earnings Results MNOV Earnings Results LABP Earnings Results TPST Earnings Results MRNS Earnings Results ASRT Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: CSX Co.: The Railroad Powering Ahead with an Earnings Beat What's Driving Tesla Lower Ahead of its Earnings?Blackrock vs. State Street: Earnings in a Volatile MarketWhat to Expect From the Q1 Earnings Reporting SeasonLululemon Stock Implodes Post Earnings, Guidance Muted Applied Optoelectronics earnings dumper, pain now for gain later?Is Roku worth a second look after the earnings panic selloff? This page (NASDAQ:CARM) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingBiden’s $374B Giveaway Into This SectorDTIForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressHe Is Giving Away BitcoinCrypto Swap ProfitsThe #1 Crypto for 2024InvestorPlaceUrgent alert: open this for a huge profit potentialTimothy SykesHow Biden has already won 2024Porter & CompanyOptions trading has suddenly become more reliable.Eagle Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Carisma Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.